[go: up one dir, main page]

BG105011A - Composition containing paroxetine - Google Patents

Composition containing paroxetine

Info

Publication number
BG105011A
BG105011A BG105011A BG10501100A BG105011A BG 105011 A BG105011 A BG 105011A BG 105011 A BG105011 A BG 105011A BG 10501100 A BG10501100 A BG 10501100A BG 105011 A BG105011 A BG 105011A
Authority
BG
Bulgaria
Prior art keywords
composition containing
containing paroxetine
hemihydrate
paroxetine
formulated
Prior art date
Application number
BG105011A
Other languages
Bulgarian (bg)
English (en)
Inventor
David Elder
Graham LEONARD
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BG105011A publication Critical patent/BG105011A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
BG105011A 1998-05-13 2000-11-30 Composition containing paroxetine BG105011A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810180.1A GB9810180D0 (en) 1998-05-13 1998-05-13 Novel formulation
PCT/GB1999/001522 WO1999058116A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (1)

Publication Number Publication Date
BG105011A true BG105011A (en) 2001-07-31

Family

ID=10831926

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105011A BG105011A (en) 1998-05-13 2000-11-30 Composition containing paroxetine

Country Status (20)

Country Link
EP (1) EP1077685A2 (xx)
JP (1) JP2002514593A (xx)
KR (1) KR20010043545A (xx)
CN (1) CN1309557A (xx)
AP (1) AP2000001985A0 (xx)
AU (1) AU3941099A (xx)
BG (1) BG105011A (xx)
BR (1) BR9910402A (xx)
CA (1) CA2331849A1 (xx)
EA (1) EA200001173A1 (xx)
GB (1) GB9810180D0 (xx)
HU (1) HUP0101931A3 (xx)
ID (1) ID27018A (xx)
IL (1) IL139596A0 (xx)
NO (1) NO20005681L (xx)
PL (1) PL344872A1 (xx)
SK (1) SK16972000A3 (xx)
TR (1) TR200003351T2 (xx)
WO (1) WO1999058116A2 (xx)
ZA (1) ZA200006465B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE311883T1 (de) 1999-03-12 2005-12-15 Aesica Pharmaceuticals Ltd Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
WO2013145750A1 (ja) * 2012-03-29 2013-10-03 杏林製薬株式会社 カプセル製剤
DE102013207447A1 (de) 2013-04-24 2014-10-30 Evonik Degussa Gmbh Verfahren und Vorrichtung zur Herstellung von Octachlortrisilan
CN103520131B (zh) * 2013-10-12 2019-05-14 浙江华海药业股份有限公司 盐酸帕罗西汀半水合物胶囊的制备方法
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9707585A (es) * 1995-04-03 1997-12-31 Abbott Lab Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada.
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation

Also Published As

Publication number Publication date
ID27018A (id) 2001-02-22
CA2331849A1 (en) 1999-11-18
CN1309557A (zh) 2001-08-22
WO1999058116A3 (en) 2000-02-17
EP1077685A2 (en) 2001-02-28
EA200001173A1 (ru) 2001-04-23
HUP0101931A3 (en) 2002-10-28
TR200003351T2 (tr) 2001-03-21
HUP0101931A2 (hu) 2002-04-29
NO20005681L (no) 2000-12-01
NO20005681D0 (no) 2000-11-10
PL344872A1 (en) 2001-11-19
AP2000001985A0 (en) 2000-12-31
JP2002514593A (ja) 2002-05-21
BR9910402A (pt) 2001-01-09
ZA200006465B (en) 2001-11-09
GB9810180D0 (en) 1998-07-08
AU3941099A (en) 1999-11-29
KR20010043545A (ko) 2001-05-25
SK16972000A3 (sk) 2001-06-11
WO1999058116A2 (en) 1999-11-18
IL139596A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
EP0609777A3 (en) Detergent composition with improved soil removal ability, process for its production and use of a suitable polycarboxylate therefor.
WO2002032898A3 (de) Neue anticholinergika, verfahren zu deren herstellung und deren verwendung als arzneimittel
PL348827A1 (en) Process for making 2,3-dihalopropanols
HUT59140A (en) Process for producing imidzoles condensed with heterocyclic group, as well as pharmaceutical compositions comprising same
WO2002032871A3 (en) Compounds and methods for treating multidrug resistance
MX9701955A (es) Antagonistas de neuroquinina.
BG105197A (en) Polymorph form of a medicament
MD970235A (en) Microcellular crystalline material, process for obtaining thereof and using thereof in washing compositions
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
BG105011A (en) Composition containing paroxetine
IL140074A0 (en) Process for preparing 1,4-dihydropyridine compounds
WO2000055287A3 (en) Perfumed detergent tablet
WO2001009122A3 (en) Serotonergic benzofurans
PL352104A1 (en) Oral composition containing perlite
BG105010A (en) Medicamentous form containing paroxetine
AU9437698A (en) Compressed chloramine-t tablets and method for the production thereof
GB9920959D0 (en) Novel process
ID27440A (id) Proses untuk menyiapkan penengah-penengah
UA41981C2 (uk) Біотинові сполуки, спосіб їх отримання, фармацевтична композиція та спосіб її отримання
CZ20022240A3 (cs) Mannichovy báze substituovaného 1-a 2-naftolu
AU7773900A (en) Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds
CA2331758A1 (en) Method for the stereochemically controlled production of isomerically pure highly substituted azacyclic compounds
YU71400A (sh) Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana
WO1999040078A3 (en) Process for the preparation of sotolon
HUT50217A (en) Process for producing aranorosine, a new antibiotic, as well as pharmaceutical compositions comprising the compound